首页> 美国政府科技报告 >ACTG 320: A Randomized Double-Blind, Phase III Study of Indinavir Sulfate (IDV) with Open-Label ZDV or Stavudine (d4T) and Lamivudine (3TC) in Subjects with HIV Infection with CD4 Cell Counts < = 200 Cells/mm3 and > = 3 Months of Prior Zidovudine Experien

【24h】

ACTG 320: A Randomized Double-Blind, Phase III Study of Indinavir Sulfate (IDV) with Open-Label ZDV or Stavudine (d4T) and Lamivudine (3TC) in Subjects with HIV Infection with CD4 Cell Counts < = 200 Cells/mm3 and > = 3 Months of Prior Zidovudine Experien

机译：aCTG 320：一项随机双盲，III期研究的印地那韦硫酸盐（IDV）与开放标签ZDV或司他夫定（d4T）和拉米夫定（3TC）的HIV感染受试者CD4细胞计数<= 200个细胞/ mm3和> = 3个月的Zidovudine Experien

获取原文

页面导航

著录项
相似文献
相关主题

著录项

作者

展开▼
作者单位

展开▼
年度 1997
页码 1-224
总页数 224
原文格式 PDF
正文语种
中图分类
关键词

相似文献

外文文献

1. Randomized, double-blind trial comparing indinavir alone, zidovudine alone and indinavir plus zidovudine in antiretroviral therapy-naive hiv-infected individuals with CD4 cell counts between 50 and 250/mm3 [J] . Artur O. Kalichman, Concei??o Accetturi, David E. Uip, Revista do Instituto de Medicina Tropical de So Paulo . 2000,第1期

机译：随机，双盲试验比较了单独使用茚地那韦，单独使用齐多夫定和茚地那韦加齐多夫定在未接受抗逆转录病毒治疗的HIV感染者中CD4细胞计数在50至250 / mm3之间
2. Sustained heavy ethanol drinking affects CD4+ cell counts in HIV-infected patients on stavudine (d4T), lamivudine (3TC) and nevirapine (NVP) treatment regimen during 9 months follow-up period [J] . Godfrey S. Bbosa, David B. Kyegombe, William W. Anokbonggo, Health . 2014,第5期

机译：持续大量饮酒会影响在9个月的随访期间接受stavudine（d4T），lamivudine（3TC）和nevirapine（NVP）治疗方案的HIV感染患者的CD4 +细胞计数
3. Discontinuation of primary and secondary prophylaxis for opportunistic infections in HIV-Infected Patients Who Had CD4+ Cell Count 200 cells/mm3 but Undetectable Plasma HIV-1 RNA: An Open-Label Randomized Controlled Trial [J] . ChaiwarithR., PraparattanapanJ., NuntachitN., AIDS patient care and STDs . 2013,第2期

机译：中止CD4 +细胞计数小于200细胞/ mm3但血浆HIV-1 RNA检测不到的HIV感染患者中机会性感染的一级和二级预防：一项开放标签的随机对照试验
4. Safety and Immunogenicity of H1/IC31® an Adjuvanted TB Subunit Vaccine in HIV-Infected Adults with CD4+ Lymphocyte Counts Greater than 350 cells/mm3: A Phase II Multi-Centre Double-Blind Randomized Placebo-Controlled Trial [O] . Klaus Reither, Lynn Katsoulis, Trevor Beattie, -1

机译：H1 /IC31®（一种辅助性TB亚单位疫苗）在HIV感染的CD4 +淋巴细胞计数大于350细胞/ mm3的成年人中的安全性和免疫原性：II期多中心双盲随机安慰剂对照试验
5. Randomized, double-blind trial comparing indinavir alone, zidovudine alone and indinavir plus zidovudine in antiretroviral therapy-naive hiv-infected individuals with CD4 cell counts between 50 and 250/mm3 Estudo duplo-cego, randômico comparando indinavir, zidovudina e indinavir mais zidovudina na terapia anti-retroviral de indivíduos HIV+ sem tratamento anterior, com contagem de células CD4 entre 50 e 250/mm3 [O] . David S. LEWI, Jamal M. SULEIMAN, David E. UIP, 2000

机译：随机，双盲试验比较了单独使用茚地那韦，单独使用齐多夫定和茚地那韦加齐多夫定在未接受抗逆转录病毒治疗的艾滋病毒感染的CD4细胞计数在50至250 / mm3之间的人的随机，双盲试验HIV +个体的抗逆转录病毒疗法，未经治疗，CD4细胞计数在50到250 / mm3之间

ACTG 320: A Randomized Double-Blind, Phase III Study of Indinavir Sulfate (IDV) with Open-Label ZDV or Stavudine (d4T) and Lamivudine (3TC) in Subjects with HIV Infection with CD4 Cell Counts < = 200 Cells/mm3 and > = 3 Months of Prior Zidovudine Experien

著录项

相似文献

相关主题

期刊订阅